Medicare Enrolled

Dr. Eric Gershman, M D

Medical Oncology · Palm Coast, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
1 MEMORIAL MEDICAL PKWY STE 200, Palm Coast, FL 32164
3865861860
In practice since 2006 (19 years)
NPI: 1316903768 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gershman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gershman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gershman

Dr. Eric Gershman is a medical oncology specialist in Palm Coast, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gershman performed 1,497 Medicare services across 253 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gershman received a total of $31,107 from 70 pharmaceutical and/or device companies across 604 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gershman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 50% volume in FL $31,107 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 55276 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
1,497
Medicare services
Top 50% in FL for medical oncology
253
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~79 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid) 734 $0 $1
Office visit, established patient (30-39 min) 145 $94 $378
Drug injection, under skin or into muscle 131 $11 $42
Complete blood count (CBC) with differential 98 $8 $23
Irrigation of implanted venous access drug delivery device 92 $19 $76
Administration of chemotherapy into vein, 1 hour or less 74 $103 $389
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 62 $23 $86
Hospital follow-up visit, moderate complexity 47 $55 $224
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 46 $47 $194
Initial hospital admission, moderate complexity 36 $100 $390
New patient office visit (45-59 min) 18 $105 $492
Office visit, established patient, complex (40-54 min) 14 $89 $554
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.2% high complexity
62.7% medium
30.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$31,107
Total received (2018-2024)
Avg $4,444/year across 7 years
Top 19% in FL for medical oncology
70
Companies
604
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,340 (42.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,115 (42.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,652 (15.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,300
2023
$874
2022
$10,264
2021
$1,749
2020
$5,118
2019
$5,434
2018
$3,369

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$6,674
SERVIER PHARMACEUTICALS LLC
$4,518
Pfizer Inc.
$2,520
BeiGene USA, Inc.
$1,925
Amgen Inc.
$1,357
Novartis Pharmaceuticals Corporation
$1,268
Incyte Corporation
$1,148
PFIZER INC.
$1,138
BeiGene, Ltd.
$975
E.R. Squibb & Sons, L.L.C.
$797
Regeneron Healthcare Solutions, Inc.
$684
Daiichi Sankyo Inc.
$645
GENZYME CORPORATION
$456
Astellas Pharma US Inc
$452
Foundation Medicine, Inc.
$438
Janssen Biotech, Inc.
$437
Seagen Inc.
$414
Celgene Corporation
$404
SANOFI-AVENTIS U.S. LLC
$373
Genentech USA, Inc.
$354
Merck Sharp & Dohme Corporation
$308
Takeda Pharmaceuticals U.S.A., Inc.
$300
Bayer HealthCare Pharmaceuticals Inc.
$299
EISAI INC.
$199
TESARO, Inc.
$196
Rigel Pharmaceuticals, Inc.
$188
Exelixis Inc.
$175
Pharmacyclics LLC, An AbbVie Company
$170
SOBI, INC
$154
Lexicon Pharmaceuticals, Inc.
$153
Sobi, Inc
$151
Seattle Genetics, Inc.
$147
Lilly USA, LLC
$146
EMD Serono, Inc.
$119
Regeneron Pharmaceuticals, Inc.
$107
Gilead Sciences, Inc.
$96
Octapharma USA, Inc.
$95
ABBVIE INC.
$95
Taiho Oncology, Inc.
$94
Eisai Inc.
$74
NOVARTIS PHARMACEUTICALS CORPORATION
$62
Merck Sharp & Dohme LLC
$56
Dendreon Pharmaceuticals LLC
$54
Spectrum Pharmaceuticals Inc.
$54
Shire North American Group Inc
$45
Myovant Sciences Inc.
$42
Collegium Pharmaceutical, Inc.
$41
Sun Pharmaceutical Industries Inc.
$39
Janssen Pharmaceuticals, Inc
$33
Teva Pharmaceuticals USA, Inc.
$32
Alexion Pharmaceuticals, Inc.
$29
Puma Biotechnology, Inc.
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Karyopharm Therapeutics Inc.
$27
MACROGENICS, INC.
$25
Pharmacyclics LLC, an AbbVie Company
$23
Clovis Oncology, Inc.
$22
Mylan Institutional Inc.
$22
CTI BioPharma Corp.
$21
MorphoSys, US Inc.
$21
EUSA Pharma (US) LLC
$19
MEDIVATION FIELD SOLUTIONS LLC
$17
Novocure Inc.
$17
GlaxoSmithKline, LLC.
$17
AbbVie, Inc.
$16
CSL Behring
$16
Verastem, Inc.
$16
Global Blood Therapeutics, Inc.
$15
Agios Pharmaceuticals, Inc.
$14
BTG International, Inc.
$13
Top 3 companies account for 44.1% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · Alecensa · Aliqopa · Aranesp · Avastin · BALVERSA · BENDEKA · BOSULIF · BRUKINSA · Bavencio · Blincyto · CABLIVI · CALQUENCE · CHANTIX · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DAURISMO · DOPTELET · ELAHERE · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · Erleada · FASLODEX · FOUNDATIONONE · Folotyn · GAZYVA · GILOTRIF · GLEEVEC · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KYMRIAH · Kcentra · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MARGENZA · MEKINIST · MONJUVI · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ODOMZO · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · Ogivri · Oncology · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PROMACTA · PROVENGE · Perjeta · Pomalyst · Prolia · REBLOZYL · RUXIENCE · RYDAPT · Revlimid · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOLIRIS · SUTENT · Stivarga · Sylvant · TAGRISSO · TALZENNA · TASIGNA · TECENTRIQ · TIBSOVO · TUKYSA · Tavalisse · Trodelvy · Turalio · VELCADE · VONJO · VORAXAZE · VPRIV · Venclexta · Vitrakvi · Vonjo · WILATE · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XPOVIO · XTAMPZA · XTANDI · Xermelo · Xofigo · Xtampza ER · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (43%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $2,078 per 100 Medicare services performed
Looking for a medical oncology specialist in Palm Coast?
Compare medical oncologists in the Palm Coast area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
2
Per 100K population
1.6
County median income
$72,923
Nearest hospital
AdventHealth Palm Coast
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gershman is a mixed practice specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 19% of FL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gershman experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Gershman performed 734 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gershman receive payments from pharmaceutical companies?
Yes. Dr. Gershman received a total of $31,107 from 70 companies across 604 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gershman's costs compare to other medical oncologists in Palm Coast?
Dr. Gershman's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gershman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →